The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological research Roots Analysis has announced the addition of “RNAi Therapeutics Market (2nd Edition), 2019-2030” report ...
Discy Latest Questions
Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a thre at; COVID-19 has been recently added to the list Roots Analysis is pleased to ...
Despite having been available for more than two decades, the demand for prefilled syringes continues to grow, given the numerous benefits they offer over conventional injectable drug delivery systems Roots Analysis is pleased to announce the publication of its recent study, ...
Due to technological advancements in drug discovery, the domain of peptides and macrocycles has once again garnered significant interest from various stakeholders in the recent past. Roots Analysis has announced the addition of “Peptides and Macrocycle Drug Discovery: Services and ...
Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile materials; in this context, elastomers have demonstrated significant potential Roots Analysis is pleased to announce the publication of its recent study, titled, “
The Growing Biopharma Industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several foreign sponsors entities over the last few years Roots Analysis is pleased to announce the publication ...
Recent technological advances in the field of ophthalmology and the availability of new biomaterials have substantially expanded the range of potential application areas of contact lenses and enabled the development of novel prosthetic products Roots Analysis is pleased to announce the ...